Brevan Howard Capital Management LP Has $6.23 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Brevan Howard Capital Management LP lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 57.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,621 shares of the company’s stock after selling 19,491 shares during the quarter. Brevan Howard Capital Management LP’s holdings in HCA Healthcare were worth $6,231,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC grew its holdings in HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the period. Sivia Capital Partners LLC lifted its stake in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the period. Allworth Financial LP increased its holdings in HCA Healthcare by 21.8% in the second quarter. Allworth Financial LP now owns 972 shares of the company’s stock valued at $372,000 after purchasing an additional 174 shares during the last quarter. Finally, Clearstead Trust LLC boosted its holdings in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HCA. Sanford C. Bernstein set a $541.00 price target on shares of HCA Healthcare in a research report on Monday, February 9th. Mizuho increased their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a report on Friday, January 30th. Wall Street Zen cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Finally, Morgan Stanley lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target on the stock. in a research report on Monday, December 15th. Sixteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $537.73.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $533.39 on Monday. The firm has a market cap of $119.28 billion, a price-to-earnings ratio of 18.79, a price-to-earnings-growth ratio of 1.64 and a beta of 1.34. HCA Healthcare, Inc. has a one year low of $313.21 and a one year high of $556.52. The stock’s 50-day moving average is $507.05 and its 200-day moving average is $470.48.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter last year, the firm earned $6.22 EPS. HCA Healthcare’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s payout ratio is 10.15%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.